Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Deep Vein Thrombosis Market Evolve in Terms of Growth and Size by 2029?

The market size for deep vein thrombosis has been on a consistent rise in the past few years. It is projected to expand from $1.06 billion in 2024 and reach $1.09 billion in 2025, registering a compound annual growth rate (CAGR) of 3.1%. The previously observed growth can be attributed to factors such as the rise in specialization within vascular medicine, the impact of medical guidelines, a concentrated effort on preventing thrombosis, advancements in clinical research, and an increase in awareness surrounding diagnosis.

There is an anticipation for substantial and consistent development in the deep vein thrombosis market, with projections reaching to “$1.3 billion by 2029 with a compound annual growth rate (CAGR) of 4.4%.” Factors contributing to this upward trajectory within the forecast period encompass an increase in the elderly population, a surge in lifestyle-related diseases, emphasis on preventative healthcare, novel therapeutic approaches, and a shift towards patient-focused care. Key trends expected during this forecast period include heightened awareness of risk factors, progress in diagnostic techniques, innovation in treatments, initiatives in public health, and preventative measures post-surgery.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10616&type=smp

What factors are expected to fuel Deep Vein Thrombosis market growth in the coming years?

The rise in the patient population necessitating deep vein thrombosis (DVT) treatment is poised to fuel the expansion of the deep vein thrombosis market in the future. Therapies for DVT involve the use of medications such as anticoagulants to inhibit the formation of new blood clots and prevent existing ones from enlarging, thereby improving the patient’s condition. The escalating count of patients needing DVT treatments signals an upsurge in the occurrence of deep vein thrombosis demanding solutions for its diagnosis, prevention, and treatment. To illustrate, the Centers for Disease Control and Prevention (CDC), a national public health entity based in the US, reported in February 2023 that nearly 900,000 Americans could be affected by deep vein thrombosis annually, with 60,000 to 100,000 Americans passing away each year due to DVT or PE (pulmonary embolism). Hence, the growing number of people needing deep vein thrombosis (DVT) treatment is propelling the market’s progress.

What Are The Key Findings From The Segmentation Analysis Of The Deep Vein Thrombosis Market?

The deep vein thrombosis market covered in this report is segmented –

1) By Drug Class: Anticoagulants, Inferior Vena Cava Filters, Other Drug Class

2) By Treatment: Surgery, Drugs, Other Treatments

3) By Mode Of Administration: Injectable, Oral, Other Modes Of Action

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-users

Subsegments:

1) By Anticoagulants: Direct Oral Anticoagulants (DOACs), Vitamin K Antagonists, Low Molecular Weight Heparins, Unfractionated Heparin

2) By Inferior Vena Cava Filters: Retrievable IVC Filters, Permanent IVC Filters, Advanced IVC Filter Systems

3) By Other Drug Class: Thrombolytics, Antiplatelet Agents, Fibrinolytics, Combination Therapy

What Upcoming Trends Are Expected To Impact The Deep Vein Thrombosis Market Globally?

One noticeable trend emerging in the deep vein thrombosis market is the surge in product innovations. The prominent companies involved in this market are leveraging fresh technologies to create new products and maintain their market standing. For instance, Penumbra Inc., a US-based creator of innovative therapy options, introduced an advanced mechanical thrombectomy system called Lightning Flash in January 2023. This system, which addresses venous and pulmonary thrombus, is powered by Penumbra’s unique lightning-intelligent aspiration technology and cutting-edge dual clot detection algorithms. It is engineered to promptly eliminate extensive blood clots, inclusive of venous thrombus and pulmonary emboli (PE). It equips doctors with a high torquing, larger catheter aimed at effectively eradicating considerable clot burdens in the pulmonary arteries or deep venous system, all while maintaining an exceptional safety profile.

What Are The Most Active Companies In The Deep Vein Thrombosis Market Today?

Major companies operating in the deep vein thrombosis market include Abbott Laboratories, Bristol-Myers Squibb Company, Sanofi-Aventis U.S. LLC, Daiichi Sankyo Company Limited, Aspen Pharmacare Holdings Limited, Novartis AG, Mylan N.V., Bayer AG, Boehringer Ingelheim GmbH, Medtronic PLC, Hikma Pharmaceuticals PLC, Laboratorios Farmacéuticos Rovi S.A., Cardinal Health Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, Stryker Corporation, Cook Medical Incorporated, Boston Scientific Corporation, Arjo AB, DJO Global Inc., Zimmer Biomet Holdings Inc., Devon Medical Products LLC, ThermoTek USA Inc., Pfizer Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/deep-vein-thrombosis-global-market-report

Which Regional Markets Are Attracting The Most Investment In Deep Vein Thrombosis?

North America was the largest region in the deep vein thrombosis market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global deep vein thrombosis market report during the forecast period. The regions covered in the deep vein thrombosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10616&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model